157 related articles for article (PubMed ID: 37316441)
21. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
Zhang J; Wang C; Tang Y; Peng H; Ye ZC; Li CC; Lou TQ
Nephrology (Carlton); 2013 Feb; 18(2):125-31. PubMed ID: 23134230
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
Soleymanian T; Najafi I; Salimi BH; Broomand B
Ren Fail; 2011; 33(6):572-7. PubMed ID: 21663387
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Value of Mesangial C4d Staining in IgA Nephropathy: A Tunisian Study.
Jebali H; Ghabi H; Mami I; Fatma LB; Haouet S; Mahjouba HB; Hmida FB; Raies L; Zouaghi MK
Saudi J Kidney Dis Transpl; 2021; 32(3):691-698. PubMed ID: 35102910
[TBL] [Abstract][Full Text] [Related]
24. Individuals of Pacific Asian origin with IgA nephropathy have an increased risk of progression to end-stage renal disease.
Barbour SJ; Cattran DC; Kim SJ; Levin A; Wald R; Hladunewich MA; Reich HN
Kidney Int; 2013 Nov; 84(5):1017-24. PubMed ID: 23739233
[TBL] [Abstract][Full Text] [Related]
25. Treatment effects of Chinese medicine (Yi-Qi-Qing-Jie herbal compound) combined with immunosuppression therapies in IgA nephropathy patients with high-risk of end-stage renal disease (TCM-WINE): study protocol for a randomized controlled trial.
Li S; Li JP
Trials; 2020 Jan; 21(1):31. PubMed ID: 31907076
[TBL] [Abstract][Full Text] [Related]
26. Validation of an international prediction model including the Oxford classification in Korean patients with IgA nephropathy.
Hwang D; Choi K; Cho NJ; Park S; Yu BC; Gil HW; Lee EY; Choi SJ; Park MY; Kim JK; Hwang SD; Kwon SH; Jeon JS; Noh H; Han DC; Kim H
Nephrology (Carlton); 2021 Jul; 26(7):594-602. PubMed ID: 33624915
[TBL] [Abstract][Full Text] [Related]
27. Clinical course of Immunoglobulin A nephropathy with crescents in a multi-ethnic Southeast Asian cohort.
Lim CC; Baikunje S; Choo JCJ; Tan PH; Foo M; Woo KT
Nephrology (Carlton); 2020 Sep; 25(9):708-713. PubMed ID: 32400945
[TBL] [Abstract][Full Text] [Related]
28. The correlation analysis between the Oxford classification of Chinese IgA nephropathy children and renal outcome - a retrospective cohort study.
Wu H; Xia Z; Gao C; Zhang P; Yang X; Wang R; Wang M; Peng Y
BMC Nephrol; 2020 Jul; 21(1):247. PubMed ID: 32611399
[TBL] [Abstract][Full Text] [Related]
29. External validation of the international prediction tool in Korean patients with immunoglobulin A nephropathy.
Joo YS; Kim HW; Baek CH; Park JT; Lee H; Lim BJ; Yoo TH; Moon KC; Chin HJ; Kang SW; Han SH
Kidney Res Clin Pract; 2022 Sep; 41(5):556-566. PubMed ID: 35545218
[TBL] [Abstract][Full Text] [Related]
30. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy.
Barbour SJ; Coppo R; Zhang H; Liu ZH; Suzuki Y; Matsuzaki K; Er L; Reich HN; Barratt J; Cattran DC;
Kidney Int; 2022 Jul; 102(1):160-172. PubMed ID: 35490842
[TBL] [Abstract][Full Text] [Related]
31. The MEST score provides earlier risk prediction in lgA nephropathy.
Barbour SJ; Espino-Hernandez G; Reich HN; Coppo R; Roberts IS; Feehally J; Herzenberg AM; Cattran DC; ;
Kidney Int; 2016 Jan; 89(1):167-75. PubMed ID: 26759049
[TBL] [Abstract][Full Text] [Related]
32. Is it possible to predict the evolution of IgAN? Validation of the IgA nephropathy progression calculator and its relationship with MEST-C score in our population.
Martín-Penagos L; Benito A; Oviedo MV; López Del Moral Cuesta C; Martín López J; Gómez Román J; López-Mejías R; Fernandez-Fresnedo G; Ruíz San Millán JC; Rodrigo Calabia E
Nefrologia (Engl Ed); 2019; 39(5):523-530. PubMed ID: 30902505
[TBL] [Abstract][Full Text] [Related]
33. Renal Interstitial Inflammation Predicts Nephropathy Progression in IgA Nephropathy: A Two-Center Cohort Study.
Zhu B; Liu WH; Lin Y; Li Q; Yu DR; Jiang F; Tang XL; Du YY; Yin JZ; Li XF; Zhong YZ; Wang WR; Sun Y; Zhang MJ; Gao YC; Yuan CY; Zhu CF; Cheng XX
Am J Nephrol; 2022; 53(6):455-469. PubMed ID: 35576899
[TBL] [Abstract][Full Text] [Related]
34. The Association of Low Hemoglobin Levels with IgA Nephropathy Progression: A Two-Center Cohort Study of 1,828 Cases.
Zhu B; Liu WH; Yu DR; Lin Y; Li Q; Tong ML; Li YY; Yang RC; Du YY; Tang XL; Jiang F; Fei D; Wei XY; Zhang FF; Yin JZ; Wang WR; Li XF; Sun Y; Zhong YZ; Zhang MJ; Cheng XX; Zhu CF; Chen HY
Am J Nephrol; 2020; 51(8):624-634. PubMed ID: 32694247
[TBL] [Abstract][Full Text] [Related]
35. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
Coppo R; Lofaro D; Camilla RR; Bellur S; Cattran D; Cook HT; Roberts IS; Peruzzi L; Amore A; Emma F; Fuiano L; Berg U; Topaloglu R; Bilginer Y; Gesualdo L; Polci R; Mizerska-Wasiak M; Caliskan Y; Lundberg S; Cancarini G; Geddes C; Wetzels J; Wiecek A; Durlik M; Cusinato S; Rollino C; Maggio M; Praga M; K Smerud H; Tesar V; Maixnerova D; Barratt J; Papalia T; Bonofiglio R; Mazzucco G; Giannakakis C; Soderberg M; Orhan D; Di Palma AM; Maldyk J; Ozluk Y; Sudelin B; Tardanico R; Kipgen D; Steenbergen E; Karkoszka H; Perkowska-Ptasinska A; Ferrario F; Gutierrez E; Honsova E
Pediatr Nephrol; 2017 Jan; 32(1):139-150. PubMed ID: 27557557
[TBL] [Abstract][Full Text] [Related]
36. Hematuria was a high risk for renal progression and ESRD in immunoglobulin a nephropathy: a systematic review and meta-analysis.
He P; Wang H; Huang C; He L
Ren Fail; 2021 Dec; 43(1):488-499. PubMed ID: 33685345
[No Abstract] [Full Text] [Related]
37. Long-term risk of ESRD in IgAN; validation of Japanese prognostic model in a Norwegian cohort.
Bjørneklett R; Vikse BE; Bostad L; Leivestad T; Iversen BM
Nephrol Dial Transplant; 2012 Apr; 27(4):1485-91. PubMed ID: 21821835
[TBL] [Abstract][Full Text] [Related]
38. Urinary Matrix Metalloproteinase 7 and Prediction of IgA Nephropathy Progression.
Yang X; Ou J; Zhang H; Xu X; Zhu L; Li Q; Li J; Xie D; Sun J; Zha Y; Li Y; Tian J; Liu Y; Hou FF
Am J Kidney Dis; 2020 Mar; 75(3):384-393. PubMed ID: 31606236
[TBL] [Abstract][Full Text] [Related]
39. Uric Acid as a Predictor of Immunoglobulin A Nephropathy Progression: A Cohort Study of 1965 Cases.
Zhu B; Yu DR; Lv JC; Lin Y; Li Q; Yin JZ; Du YY; Tang XL; Mao LC; Li QF; Sun Y; Liu L; Li XF; Fei D; Wei XY; Zhu CF; Cheng XX; Chen HY; Wang YJ
Am J Nephrol; 2018; 48(2):127-136. PubMed ID: 30110674
[TBL] [Abstract][Full Text] [Related]
40. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
